0001 1 IN THE COURT OF COMMON PLEAS CUYAHOGA COUNTY, OHIO 2 MARK WILLIAMS, etc., ) 3 Plaintiffs ) ) 4 vs. ) CASE NO. 406184 ) 5 PARMA COMMUNITY GENERAL ) HOSPITAL, et al, ) 6 Defendants ) 7 8 9 ORAL VIDEOTAPED DEPOSITION 10 HUNTER HAMMILL, M.D. 11 June 23, 2001 12 13 ORAL VIDEOTAPED DEPOSITION OF HUNTER HAMMILL, 14 M.D., produced as a witness at the instance of the 15 Defendants William K. Hahn, Jr. M.D., Powers 16 Professional Corporation d/b/a Women and Wellness 17 Center and duly sworn, was taken in the above-styled 18 and numbered cause on the 23rd day of June, 2001, 19 from 9:30 a.m. to 10:47 a.m., before Vickie G. 20 Hildebrandt , Certified Shorthand Reporter in and for 21 the State of Texas, reported by computerized 22 stenotype machine at 7400 Fannin, Suite 950, Houston, 23 Texas. 24 25 0002 1 APPEARANCES 2 3 FOR PLAINTIFFS: 4 Mr. David M. Paris Nurenberg, Plevin, Heller & McCarthy 5 1370 Ontario Avenue, First Floor Cleveland, Ohio 44113 6 FOR DEFENDANTS WILLIAM K. HAHN, JR., M.D., POWERS 7 PROFESSIONAL CORPORATION D/B/A WOMEN AND WELLNESS CENTER: 8 Mr. William D. Bonezzi 9 Bonezzi, Switzer, Murphy & Polito 1400 Leader Building 10 526 Superior Avenue Cleveland, Ohio 44114-1491 11 12 ALSO PRESENT: 13 Paul Richardson, Videographer 14 15 16 17 18 19 20 21 22 23 24 25 0003 1 2 INDEX 3 PAGE 4 HUNTER HAMMILL, M.D. 5 Examination by Mr. Bonezzi .................... 4 Examination by Mr. Paris ...................... 38 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 0004 1 THE COURT REPORTER: Are there any 2 stipulations? 3 MR. BONEZZI: No. 4 THE VIDEOGRAPHER: June 22nd, 5 9:30 a.m. We're now on the record. 6 HUNTER HAMMILL, M.D., 7 having been first duly sworn, testified as follows: 8 EXAMINATION 9 Q. (BY MR. BONEZZI) Would you state your name 10 for the record, please? 11 A. Hunter Hammill, M.D. 12 Q. And, Dr. Hammill, where are we presently? 13 A. We're in an office building in Houston, 14 Texas. 15 Q. Doctor, this case is going to trial 16 starting this coming Monday. Would you tell the 17 ladies and gentlemen of the jury why you will be 18 unable to appear at trial next week or possibly the 19 following week, please? 20 A. About, I guess, a week and a half ago, 21 Houston was hit with a natural disaster, flooding 22 most of the hospitals, although not the building 23 we're in, and homes, and we've had chaos. 24 Q. So you're unable to appear in Cleveland? 25 A. That's why I haven't been on the road to 0005 1 Cleveland. 2 Q. Okay. Would you give me your professional 3 address, please? 4 A. 7400 Fannin, Suite 1160, Houston, Texas. 5 Q. You are a medical doctor; is that correct? 6 A. Yes. 7 Q. Do you have an area of specialty? 8 A. I'm board certified in OB/GYN infectious 9 diseases -- correction. I'm board certified in 10 OB/GYN, and I did a fellowship in OB/GYN infectious 11 diseases. 12 Q. Doctor, could you tell us approximately how 13 many OB/GYNs are in the country who also have a 14 subspecialty in infectious disease? 15 A. There's -- there's no more than two dozen. 16 Q. In other words, there's about 24 -- maybe 17 24 obstetricians/gynecologists who also have a 18 subspecialty in infectious disease. Is that what 19 you're saying? 20 A. Tops. 21 Q. Okay. Would you be kind enough to give us 22 a little bit of information regarding your 23 background, please? Tell us where you went to 24 medical school, college, fellowships, et cetera. 25 A. I went to Boston College as an 0006 1 undergraduate. I went to Columbia College of 2 Physicians and Surgeons for -- for medical school. I 3 did a year of internal medicine at Montefiore 4 Hospital in Pittsburgh. I did my residency in OB/GYN 5 at the UCLA Medical Center in Los Angeles. I did a 6 two-year OB/GYN infectious disease fellowship with 7 Dr. Feingold in Los Angeles, and I've been on the 8 faculty at UCLA, Case Western Reserve and Baylor 9 College of Medicine. 10 Q. Do you presently hold any type of 11 appointments here in the Houston area, and if so, 12 what are they? 13 A. I'm a clinical associate professor in the 14 departments of pediatrics, family medicine and rehab. 15 Q. Now, Doctor, I want to talk just for a 16 moment about infectious diseases. To what extent 17 presently do you actually practice in the field of 18 infectious diseases as it pertains specifically to 19 either obstetrical patients or gynecologic patients? 20 A. About probably 60 to 70 percent of my 21 patients that are OB/GYN patients have -- are seeing 22 me because of some other infectious disease-related 23 matter such as they're pregnant and they have AIDS or 24 pregnant and have malaria, which would be uncommon, 25 some pregnancy variant or a gynecologic-related 0007 1 infection. 2 Q. In your practice, do you manage patients or 3 treat patients who have what are called postpartum 4 infections? 5 A. Yes, I do. 6 Q. Doctor, please explain to us what a 7 postpartum infection is, please. 8 A. Well, a postpartum infection would be 9 febrile morbidity, which means you have a temperature 10 elevation. You may have tenderness, and those would 11 be the clinical symptoms. Sometimes you have pain, 12 and I subdivide them into two groups, those who have 13 had C-sections and those who have had vaginal 14 deliveries, but any infection related to the delivery 15 after the baby is born. 16 Q. Now, the term "postpartum," what does that 17 mean? 18 A. After the delivery. Partum, the baby is 19 out. 20 Q. Approximately how many patients, if you 21 know, have postpartum infections? 22 A. Without antibiotics, if you had a C-section 23 while in labor, in some series, up to 40 percent of 24 patients would have febrile morbidity, so that's a 25 patient in labor and then they have a C-section 0008 1 because the baby didn't fit, if you will, and then 2 they have a fever. It's an empiric approach. If you 3 have -- give prophylactic antibiotics, preventative 4 antibiotics, to prevent infections in elective repeat 5 C-sections, it can be less than 10 percent. Then if 6 you look at vaginal deliveries, the infection rate is 7 usually less than 1 percent of vaginal deliveries. 8 Q. Okay. This case involves a vaginal 9 delivery; is that correct? 10 A. Yes. 11 Q. In those situations, what would you 12 estimate the percentage of patients who have 13 postpartum infections, what would it be with vaginal 14 deliveries only? 15 A. Vaginal deliveries only, as I said, would 16 be less than 1 percent of the patients would have 17 what's called febrile morbidity where it was related 18 to the uterus as opposed to mastitis, a breast 19 inflammation, so the vaginal -- post vaginal delivery 20 infections are uncommon. 21 Q. Can you tell us whether there are different 22 organisms, different bacteria, that can cause 23 postpartum infections in this class of patients that 24 you've just described? 25 A. Yes, sir, and the most -- one of the 0009 1 classics, although we fortunately don't see it 2 as -- well, fortunately we don't see it too often, is 3 if a patient had gonorrhea, was untreated and then 4 had a temperature elevation, so an STD-related 5 untreated item is one concern, but most of the 6 patients, the infection -- 7 Q. Excuse me. "SDT" is? 8 A. Sexually transmitted disease. 9 Q. Thank you. 10 A. Most of the patients that have postpartum 11 infections, it relates to the bacteria that are in 12 their vagina or, if you will, like we have on our 13 skin that for some reason ascends up into the uterus 14 and an infection starts. 15 Q. Are you familiar with a bacteria that is 16 known as Group A beta hemolytic streptococcal 17 bacteria? 18 A. Yes. 19 Q. Can you tell us whether or not there are 20 certain patients who can develop Group A 21 streptococcal infections following delivery where the 22 delivery has been a vaginal delivery? 23 A. That can occur. 24 Q. What is the percentage or likelihood of 25 that occurring in those patients? 0010 1 A. Extremely rare. This is an extremely 2 rare -- and by -- you specifically said infection? 3 Q. Yes. 4 A. Where an infection develops and then we'd 5 even extend that where a life-threatening infection 6 develops. I failed to mention -- and I'm just 7 talking about the uterus. We're not talking about 8 episiotomy infections -- 9 Q. No. 10 A. -- and things like that. 11 Q. And approximately what percentage of 12 patients develop Group A streptococcal infections 13 following a vaginal delivery? 14 A. Well, it's -- it's extremely rare, 15 especially if you include infections where toxins are 16 released and the patients get very sick. 17 Q. Can you quantify that in percentage terms? 18 A. I've seen one verified case in my life. My 19 associate, who's worked at the largest hospitals like 20 Charity Hospital and Jefferson Davis Hospital we had 21 here where we're doing combined 40,000 deliveries a 22 year, he rarely sees this, so the -- and if you look 23 at the Center for Disease Control, you know, if there 24 are -- I'd be surprised if there's more than ten 25 cases a year in the country where this type of 0011 1 infection occurs, so it's extremely rare. 2 Q. When you say "extremely rare," I want to go 3 back for a moment to your earlier comment that 4 approximately 1 percent or less than 1 percent of the 5 patients who have delivered vaginally have an 6 infection. I use that as my premise for this 7 question. Out of that 1 percent or less than 8 1 percent, how many patients percentage-wise develop 9 Group A strep infections? 10 A. I can't give an exact percentage because 11 it's so small. For example, in the system that I 12 worked in and continue to work in where at the county 13 hospital, we had 20,000 deliveries, the two private 14 hospitals, 10,000, and at the other private hospital, 15 6,000, so almost close to 36, 37,000 deliveries, if 16 we have one case of Group A strep, I can't figure out 17 the percentage of what 1 over 36,000 is, but it's 18 extremely rare. 19 Q. I want to go back to your qualifications 20 for a moment. Can you tell us whether or not at 21 least 50 percent or more of your time is spent in the 22 act of clinical practice of medicine? 23 A. Yes, it is. 24 Q. Do you currently hold any type of medical 25 licensures that allows you to practice medicine and 0012 1 if so, where? 2 A. I'm licensed in the State of Texas, the 3 State of California and the State of Ohio. 4 Q. Do you currently belong to any 5 organizations within your field of specialty or 6 expertise? 7 A. I'm a member of the American College of 8 OB/GYN. I'm a member of the OB/GYN Infectious 9 Disease Society of America, and I'm a member of the 10 International OB/GYN Infectious Disease Society, 11 which is a different group. 12 Q. Is there a difference, Doctor, if you know, 13 between the infectious disease specialty for 14 individuals who practice in internal medicine as 15 opposed to individuals whose primary practice is in 16 obstetrics and gynecology and if so, what is it? 17 A. Well, the area of OB/GYN infectious disease 18 is much like pediatric infectious disease early on. 19 It doesn't have a specific board fellowship exam, so 20 the adult infectious disease has a separate board. 21 Pediatric infectious disease, only in the last ten 22 years, I believe, developed a separate board, so 23 that's one difference, and I guess the other -- the 24 big difference is since I work with a lot of adult 25 infectious disease doctors, is they don't -- it's 0013 1 sort of a crossover because the adult infectious 2 disease physicians don't routinely see the type of 3 soft tissue infections you see in obstetrics and 4 gynecology, and that's where the specialty evolved, 5 so I'd say the big difference is we're usually called 6 in on these complicated patients usually by other 7 obstetrician/gynecologists whereas the internist 8 adult ID person may occasionally be called in on 9 these patients. 10 Q. Okay. Doctor, have you written in your 11 field of specialty? 12 A. Yes, I have. 13 Q. Have you had your writings published in 14 peer-reviewed journals? 15 A. Yes, I have. 16 Q. Can you tell us what a peer-reviewed 17 journal is? 18 A. I can tell you what it's supposed to be. 19 Q. That will be even better. 20 A. It's supposed to be a journal where if you 21 submit an article, it's usually read -- read blinded, 22 meaning the person who wrote the article's name isn't 23 known to the reviewers, and it is -- just as a jury 24 of your peers, these are colleagues of your peers. 25 For example, if it was a cardiology journal, you'd 0014 1 have a cardiologist reviewing the articles. In my 2 field, it would be obstetrician/gynecologists or 3 obstetrician/gynecologists who do infectious 4 diseases. 5 Q. Doctor, are you familiar with the term 6 known as an exotoxin, E-X-O -- 7 A. Yes, I am. 8 Q. Go ahead. What is it, please? 9 A. An exotoxin, simply put, would be a 10 substance which is secreted outside of the cell. 11 Maybe it's sort of like exhaust fumes. The car keeps 12 running, but there's stuff that's spewed out. 13 Q. And how does an exotoxin cause problems 14 with a patient who has an infection or has developed 15 sepsis? 16 A. Well, toxin, as the name would suggest, 17 toxic, toxins can do a variety of things. One of the 18 more serious things, it can break down red cells. It 19 can prevent phagocytosis, which is like the white 20 cells that eat the bacteria or destroy it, so toxins 21 are toxic to the -- to the body and it's like a 22 poison in the system and actually poisons a chain of 23 events, and it's almost like a waterfall. It starts 24 off and then the waterfall builds momentum as the 25 flood occurs, to use a Houston analogy. 0015 1 Q. I asked you before if you were familiar 2 with Group A strep. 3 A. Yes. 4 Q. To what extent is there an association 5 between the presence of a Group A streptococcal 6 bacteria and the release of exotoxins? 7 A. Well, there's an association and that's 8 what Group A strep is known for, that it has the 9 potential to release this toxin, life-threatening 10 toxin. 11 Q. Now, why is it life-threatening? 12 A. It's like a venomous snake, if you had a 13 venomous snake that had a lethal venom. Even though 14 the amount of venom that's in the person that's 15 bitten, it has a cascade effect by -- with Group A 16 strep, it, if you will, poisons a lot of the 17 functions of the -- of the body. It destroys red 18 cells. It will destroy tissues like the liver, the 19 heart, the kidneys. It will -- if you will, almost 20 like a flesh-eating bacteria that's common in the 21 press to describe it as, so it will destroy. 22 Q. You are familiar with the term "necrosis," 23 are you not? 24 A. Yes. 25 Q. To what extent will the destruction of soft 0016 1 tissue play a role in the development of necrosis, if 2 at all? 3 A. Well, soft tissue -- and by soft tissue, it 4 could be fat on your arms or legs. It could be 5 something soft like the uterus as opposed to bone, if 6 you will. Now, soft tissue and necrosis, if you 7 will, particularly in obstetrical and gynecologic 8 infections, are a difficulty because as they become 9 necrotic, as the tissue necroses or dies, the blood 10 supply to that area becomes walled off. I like to 11 use the analogy it's like a freeway at rush hour. 12 Congestion occurs, and nothing moves into where you 13 want to go. 14 Q. So, in other words, when you talk about 15 necrosis, once necrosis develops, it walls off the 16 ability of, for instance, antibiotics to be 17 delivered? 18 A. Well, it's like this: If you have blood 19 supply going to a site of tissue, once it's necrotic, 20 the blood vessels, the veins, the arteries, they're 21 not open. Nothing gets in, and they gradually -- so 22 it's harder for the body's defenses to get to a 23 target site. It's like a fort. 24 Q. Now, Doctor, at my request, you reviewed 25 certain items that pertain specifically to this case, 0017 1 have you not? 2 A. Yes. 3 Q. And without having you go through 4 everything, can you tell me if you reviewed the 5 records that were generated as a result of the 6 June 24th through June 26th, 1999 confinement at 7 Parma Community General Hospital of the decedent, 8 Mary Beth Williams? 9 A. Yes, I did. 10 Q. Did you review the transport records and 11 the records generated once she was confined at 12 University Hospitals on June 26th? 13 A. Yes, I did. 14 Q. Have you reviewed the deposition 15 transcripts of many of the experts in this case which 16 would have included Dr. Mark Martins? 17 A. Yes, I did. 18 Q. Dr. Neal Crane? 19 A. Yes. 20 Q. Dr. Keith Armatage? 21 A. Yes. 22 Q. Dr. Metha Deshan? 23 A. I'm not sure I reviewed Dr. Deshan's. 24 Q. Have you reviewed the deposition transcript 25 of the defendant, William Hahn? 0018 1 A. Yes. 2 Q. Have you reviewed the transcript of 3 Dr. Martin Raff? 4 A. I believe I did, yes. 5 Q. Have you reviewed the publication -- strike 6 that -- the -- the reports that were generated by 7 those individuals who I've just mentioned? 8 A. You mean their depositions? 9 Q. No, the reports where they set forth their 10 opinions prior to their depositions. 11 A. I don't believe I've seen those reports. 12 Q. Okay. As far as the records and the 13 reports and the depositions that have been sent, were 14 you able to form opinions in this case based upon the 15 review of those records? 16 A. Yes, I have. 17 Q. And were you able to form opinions that 18 pertain specifically to the cause of death of Mary 19 Beth Williams? 20 A. Yes, I have. 21 Q. Were you able to determine whether or not 22 William Hahn, the obstetrician who cared for Mary 23 Beth Williams from approximately 5:00 o'clock in the 24 afternoon on June 25th until the time in which she 25 was transported out to University Hospitals, met the 0019 1 acceptable standards of care for a practicing 2 obstetrician? 3 A. Yes, I've reviewed them. 4 Q. Okay. I'm going to ask you this question 5 first of all: What did Mary Beth Williams die from? 6 A. She died from Group A strep toxin-releasing 7 shock. 8 Q. Doctor, how are you able to conclude that 9 the cause of death was directly related to a toxin 10 release from the Group A strep bacteria? 11 A. I base that on the blood culture, the 12 autopsy report, which show the organism had been 13 cultured, and the systemic effect on the autopsy. 14 Q. What do you mean by systemic effect 15 relative to the autopsy? 16 A. That means she -- her kidneys shut down. 17 Her heart shut down. Also specifically they describe 18 necrotic, as you were talking about earlier, dead 19 tissue within the uterus. 20 Q. Now, let's talk about that for a moment. 21 Is that of significance to you that there were areas 22 within the uterus that demonstrated necrosis? 23 A. Yes, because if the uterus was completely 24 normal, then I would have trouble postulating what 25 occurred and where it started from but in this case, 0020 1 the necrotic areas of the uterus show that the 2 infection, as with this type of bacteria, that was 3 the nidus of the infection, the start. 4 Q. Okay. Now, Doctor, if there were areas of 5 necrosis or there was the presence of necrotic tissue 6 in the uterus, do you have an opinion based upon 7 reasonable medical probability whether or not, had 8 antibiotics been delivered at any time, whether the 9 antibiotics would have been effective in killing the 10 bacteria that were in the uterus? 11 MR. PARIS: Objection. 12 Q. (BY MR. BONEZZI) Do you have an opinion? 13 Go ahead and answer. 14 A. I have an opinion. 15 Q. What is that opinion, Doctor? 16 A. My opinion is that the necrotic tissue, the 17 dead tissue within the uterus, is, if you will, a 18 privileged site -- I use the -- use the expression 19 like a fortress -- and when the bacteria set up an 20 infection, unfortunately, in sort of an evil scheme, 21 the antibiotics, the white cells, lots of the things 22 that are part of the body's defenses, since the blood 23 supply is cut off, if you will, the roads are closed 24 or shut down, you don't get what you want to the 25 target site. 0021 1 The other problem is -- and sometimes 2 confusing -- is that you may get a good blood level 3 in your veins so if you're treating a heart 4 infection, the blood gets to the heart valve, but in 5 these kind of soft tissue infections in the uterus, 6 one of the dilemmas is that the necrotic or dead 7 tissue forms a barrier so that these anti-infective 8 agents from the body and antibiotics that are ordered 9 can't get to that site, and that's a big problem. 10 Q. Doctor, as part of your review, did you 11 review the autopsy that was performed on behalf of 12 the family of Mary Beth Williams? 13 A. Yes, I did. 14 Q. Do you recall if there were any focal areas 15 of hemorrhage within the uterus as demonstrated or 16 described in the autopsy? 17 A. Yes, there were. 18 Q. And can you tell me or tell us whether 19 there were any abnormalities involving the 20 perimetrial soft tissue within the uterus? 21 A. Yes, there were. 22 Q. Now, could you explain to us the 23 significance of, first of all, the focal areas of 24 hemorrhage and then secondly the abnormalities within 25 the soft tissue of the lining of the uterus? 0022 1 A. Okay. And I'll just say, to describe it 2 anatomically, if I can -- 3 Q. Please. 4 A. -- on the film, if I were to put my arms 5 out -- I don't know if this is on camera -- and I was 6 the uterus and these were the fallopian tubes and my 7 white coat here was where the vessels came through, 8 the perimetrium is next to the uterus and what 9 happens is this gets -- the blood supply coming in 10 gets cut off and if I want the antibiotics to get to 11 my -- where my chest is, which would be the uterus, 12 it's cut off, and the fact that there was soft tissue 13 destruction and hematoma as there's bleeding which 14 may have been caused by the toxin lysing red cells 15 and tissue dissolving and blood vessels being closed 16 like a clogged highway, that, again, is more dead 17 tissue. Just like if you get a bruise underneath 18 your skin, you have a bruise, that's -- but it's a 19 big bruise inside and it walls off, so there was a 20 large amount of tissue destruction which, from the 21 autopsy, you know, we're looking at sort of 22 afterwards, that had been destroyed. 23 Q. Do you know what caused the destruction? 24 A. The Group A strep toxin caused the 25 destruction. 0023 1 Q. Doctor, will the administration of 2 antibiotics eradicate the toxin? 3 A. The toxin won't be killed by the 4 antibiotics. 5 Q. Well, then, what's the purpose of 6 administering antibiotics if, in fact, there is a 7 belief that an infection exists? 8 A. Well, you don't know it's Group A strep. 9 You don't even know there's a toxin release and one 10 of the things that occurs in obstetrical infections, 11 differing a little bit from the bladder infection or 12 spinal fluid infection or even routine sepsis -- and 13 I don't want to use the word "routine," but where the 14 bacteria in the blood -- is that the antibiotics 15 sometimes will suppress sepsis, meaning we know we 16 get a high blood level, high amount of antibiotics in 17 the blood, and we know from laboratory studies that 18 if you have "X" organism, it will be killed by "X" 19 bacteria at a certain level, and that's how we 20 correlate choosing antibiotics and that's how drug 21 companies make antibiotics and narrows the standards 22 to report to killing bacteria. 23 One of the problems, again, in 24 obstetrical infections, the target tissue, meaning 25 like my tummy if I was the uterus, the antibiotics -- 0024 1 the root to the infection is cut off, if you will, as 2 tissue is necrotic, and that's why surgeons drain 3 things, so it's like -- and normally the uterus 4 is -- can be like a self-draining abscess through the 5 cervix, but not always, and that's why with necrotic 6 tissue, you can't get the same levels, but we do give 7 antibiotics to suppress sepsis and hopefully to get a 8 small amount of antibiotics to where we want them to 9 go, but until you -- you know, and fortunately, in 10 this case, there's an autopsy -- you don't know 11 what's going on. It's empiric treatment. 12 Q. In obstetrics, and specifically with you 13 treating patients with a suspected infection, do you 14 always know where the target of the infection happens 15 to be? 16 A. Well, we use the if you hear hoofbeats, 17 it's probably horses, not zebras, so if you just had 18 brain surgery, you probably had a brain abscess. If 19 I operate on your bladder, that, and in an 20 obstetrical case, it's usually the uterus, tubes and 21 ovaries. Sometimes in a postpartum patient, it is 22 the breast; so it depends what's going on. Depends 23 on a lot of background information. 24 Q. In a case such as the one that we're here 25 on today, if antibiotics would have been delivered, 0025 1 for instance, at or by 5:00 o'clock in the afternoon 2 of June 25th, 1999, can you tell us whether or not 3 the delivery of antibiotics would have had any effect 4 on Mary Beth Williams' condition and then secondly, 5 would it have changed the outcome in this case? 6 MR. PARIS: Objection. 7 A. I don't think it would have had -- the only 8 effect it might have had, it might have suppressed 9 the bacteremia, the bacteria that might be in the 10 bloodstream. It would not have affected the toxin; 11 and, again, the toxin is like a venom. Once it's in 12 the system, you have a problem, and in retrospect, 13 having seen the autopsy report, with the necrotic 14 tissue, the antibiotics wouldn't have reached that 15 site. 16 MR. PARIS: Move to strike. 17 Q. (BY MR. BONEZZI) Doctor, I'm going to be 18 asking you some opinion questions in this case for 19 the next couple of minutes, and I would ask that you 20 answer your -- the questions to a reasonable degree 21 of medical probability. Will you do that? 22 A. Yes. 23 Q. Okay. Now, you read the records, as you've 24 already testified? 25 A. Yes. 0026 1 Q. And you would have been able to determine 2 what the clinical presentation of Mary Beth Williams 3 was from approximately 1550 or ten minutes till 4:00 4 in the afternoon throughout the rest of the evening 5 of June 25th and into the morning hours of the 26th, 6 correct? 7 A. Yes. 8 Q. Can you tell us whether there were any 9 changes in her clinical presentation between 10 approximately 4:00 o'clock in the afternoon until 11 approximately 4:00 o'clock in the morning, and if so, 12 what were those changes? 13 A. Well, I would just qualify, I'd want to 14 look at the records specifically for the time. 15 However, as I recall, the patient had some blurred 16 vision, had some shakes, and I'm not sure if that's 17 the time framework when she had the temperature 18 elevation -- 19 Q. And do you recall -- 20 A. -- but that is my summary feeling as to 21 what went on. 22 Q. Okay. I want you to assume for purposes of 23 this question that she developed what has been called 24 shaking and shivering at approximately 1550 in the 25 afternoon. 0027 1 A. Yes. 2 Q. In retrospect, can you tell us what you 3 believe, what your opinion is, relative to the cause 4 of the shaking and the shivering? 5 A. In retrospect, this was an infection. 6 Q. Are you aware of why she was admitted to 7 the hospital, by the way, on June 24th? 8 A. She was admitted -- my understanding is 9 that she had some signs or stigmata of a 10 pregnancy-related hypertension syndrome or 11 pregnancy-induced hypertension and that's why they 12 wanted to expedite the delivery because PIH, as it's 13 called, is cured by the delivery usually and that is 14 a very serious, potentially life-threatening 15 condition if it progresses. 16 Q. By the way, are you familiar with the term 17 "virulence"? 18 A. Yes. 19 Q. What is that as it relates to an infection 20 or sepsis? 21 A. Virulence, I guess you could call it, is 22 how tough you're going to be. Are you going to be 23 punched by George Forman or am I going to be 24 punched -- 25 Q. Me. 0028 1 A. -- by you, so it's sort of how tough, how 2 strong. Is a tank going to drive over you or a 3 Volkswagen? I mean, virulence is how terrible, how 4 dangerous, if you will, in layman's terms. That's 5 how I describe it. 6 Q. Do you have an opinion in this case 7 relative to the virulence of the Group A strep that 8 ultimately caused the death of Mary Beth Williams? 9 A. This was a highly virulent organism, lethal 10 virulence. 11 Q. Doctor, I want you to presume for purposes 12 of this question that a CBC or complete 13 white -- complete blood count was obtained at 14 approximately 5:00 o'clock in the afternoon on 15 June 25th -- 16 A. Yes. 17 Q. -- and the white count was about 16.1 -- 18 A. Yes. 19 Q. -- without a differential, all right? 20 A. Okay. 21 Q. I want you further to presume that another 22 CBC was obtained and the white count at approximately 23 2330 or 11:30 in the evening on June 25th had now 24 dropped to 4.6. I want you further to presume for 25 purposes of this question that a differential was 0029 1 obtained at 5:00 o'clock and a differential was 2 obtained also at 11:30 or 2330 and that the 3 differential demonstrated a left shift as it did 4 previously in the day and also a further left shift 5 at 11:30 in the evening, okay? I want you to presume 6 all of that for purposes of this question. Are you 7 able to extrapolate from that white count of 16.1 at 8 approximately 5:00 o'clock in the evening -- and by 9 the way, the left shift included bands which were 10 approximately 13 percent -- vis-a-vis or versus the 11 white count of 4.6 at approximately 11:30 p.m. with 12 bands that were as high as 52 percent. Can you 13 extrapolate and tell us whether or not that provides 14 you, as a physician who specializes in obstetrics and 15 infectious disease, to determine the virulence of the 16 organism? First of all, can you do it? 17 A. Yes. 18 Q. Tell us about it, please. 19 MR. PARIS: Objection. 20 A. The fact that normally white cells are a 21 measurement, first of all, of how -- the body's 22 defenses and a 16,000 white count with what you call 23 the bandemia or left shift would be a sign of an 24 infection and normally if the white count were to 25 drop, we'd say that's a good sign because the 0030 1 infection is getting better but in this particular 2 case, the fact that the white count drops to a level 3 and the -- if, as you said, the number of bands 4 increases, in very serious, life-threatening 5 infections, the body is so overwhelmed, its immune 6 system doesn't work the same way and, if you will, 7 the white cell producing system is in shock so 8 instead of having an enormously high white count, you 9 have an enormously low one, so, again, in this 10 clinical setting, in retrospect, this would suggest 11 that this was a virulent toxin that was able to 12 inhibit the body's defenses further and, if you will, 13 lead to the shock. 14 Q. (BY MR. BONEZZI) For purposes of this 15 question, Doctor, I want you to presume that a 16 temperature was obtained on behalf of Mrs. Williams 17 at approximately 1930 or 7:30 in the evening and 18 there was a spike in her temperature to 101.6. I want 19 you to presume that for purposes of this question. I 20 want you further to presume that there will be 21 testimony in this case that certain experts who are 22 providing testimony on behalf of the plaintiffs have 23 stated that antibiotics should have been given 24 shortly thereafter or after the temperature spike was 25 determined or detected, all right? 0031 1 A. (Nods head.) 2 Q. Would you accept that? 3 A. That they said this, yes. 4 Q. Do you have an opinion based upon 5 reasonable medical probability, had antibiotics been 6 administered, say, by 8:30 in the evening because of 7 the temperature spike and because of other clinical 8 presentations of the patient, whether antibiotics 9 would have altered the outcome and prevented the 10 death of Mary Beth Williams? Do you have an opinion? 11 A. I have an opinion. 12 Q. What is it? 13 A. That it would not have altered the course. 14 Q. Please explain that to us. 15 A. Well, the -- if a patient has a vaginal 16 delivery -- and we see lots of patients with vaginal 17 deliveries that have fevers to 101 that are often, if 18 you will, ignored. The white count doesn't come back 19 for a day. The antibiotics aren't started and they 20 have fevers and white counts and then they start the 21 antibiotics even a day or two later, they live. They 22 live. This particular patient -- and I would daresay 23 many patients -- most patients with an infection like 24 this after a vaginal -- not like this -- a febrile 25 morbidity after a vaginal delivery would live even 0032 1 without antibiotics. Now, they might develop some 2 inflammation and some pelvic pain, but they'd be 3 alive. In this particular case, what makes it 4 difficult is this patient presenting -- presented 5 with a syndrome which is life-threatening which is 6 very commonly associated with death, the 7 pregnancy-induced hypertension, and she was seen and 8 evaluated for that -- I won't say common but 9 far -- far more reported serious, life-threatening 10 condition of the pregnancy-induced hypertension, but 11 in this particular case, at a vaginal delivery for 12 unknown reasons, this particular Group A strep 13 colonized or was in her uterus and we see -- and even 14 that wouldn't be life-threatening, even that type of 15 infection. However, this particular isolate released 16 its toxin, so the fact that it released the toxin is 17 what -- and is a toxin-releasing Group A strep, 18 whatever triggered that killed her, and the problem 19 also is that as the tissue is necrotic, even if it's 20 a small area, antibiotics don't get to that site so 21 if you're saying antibiotics could have gotten to the 22 site and killed the bacteria, what I'd say is the 23 necrotic area would have prevented the antibiotics 24 getting there, did prevent the antibiotics from 25 getting there and furthermore, when the toxin is 0033 1 released, it's a cascade effect that antibiotics do 2 not effect. 3 MR. PARIS: Objection. Move to 4 strike. Unresponsive. 5 Q. (BY MR. BONEZZI) I think it was very 6 responsive, Doctor. Thank you. 7 When the placenta is delivered 8 following the birth of the infant, to what extent, if 9 at all, does that have an impact on the lining of the 10 uterus? 11 A. The placenta is like a big pie. It's 12 actually almost the size of a pie and when -- and the 13 uterus is bigger, maybe this size (indicating), and 14 it shrinks down to maybe the size of both my fists 15 together and when the placenta is delivered, there's 16 an area that is raw, if you will, weeping, and the 17 blood vessels contract and that's why, when the 18 placenta is delivered, the blood vessels contract but 19 there's a raw surface and then that heals. That 20 seals over. 21 Q. Are you familiar with the term 22 "devascularization"? 23 A. Yes, I am. 24 Q. To what extent does the removal of the 25 placenta cause or develop an area of 0034 1 devascularization in the uterus? 2 A. Well, what happens is -- and this is part 3 of the design plan of why we're alive -- is as the 4 uterus contracts down, those vessels constrict and 5 that bleeding, raw area constricts and if you will -- 6 that's -- that's one of the things that is supposed 7 to occur where that -- that area of bleeding from the 8 placenta bed closes off. 9 Q. Can antibiotics, if administered, be 10 delivered to the area in which there is 11 devascularization? 12 A. Well, they'd have to seep in and since the 13 antibiotics go through the bloodstream and they 14 weren't given directly into the uterus or into the 15 soft tissue, they would have trouble reaching a 16 devascularized area. 17 Q. If there is a suspected infection, not 18 knowing what the organism is but believed to be in 19 the uterus, what would be the common or normal dosage 20 of the antibiotic? 21 A. Well, it depends on the antibiotic. 22 Q. Let's say penicillin. 23 A. Penicillin you give in dosages of millions 24 of units. Ampicillin you give in grams. Some other 25 antibiotics you give in milligrams. 0035 1 Q. Let's take Ampicillin. 2 A. Okay. 3 Q. What would be the common or acceptable 4 dosage to be given empirically -- 5 A. It would range -- 6 Q. -- for a suspected uterine infection? 7 A. It would range anywhere from 500 milligrams 8 to 2 grams anywhere from every three to six hours. 9 Q. Can you tell us whether or not that dosage, 10 had it been given at 7:30, 8:30, 9:30, 10:30 on the 11 evening of June 25th, would have had an impact on the 12 likely, I guess, staying alive of Mary Beth Williams? 13 In other words, would she have died? 14 MR. PARIS: Objection. 15 A. She would have died. 16 Q. (BY MR. BONEZZI) Okay. So, in other words, 17 even had what would have been considered the 18 appropriate degree or dosage of antibiotics, had it 19 been given to her at any time during the evening of 20 June 25th, would it have altered the outcome in any 21 way? 22 A. No. 23 MR. PARIS: Objection. 24 Q. (BY MR. BONEZZI) Okay. Doctor, did you 25 review these records sufficiently enough to form an 0036 1 opinion relative to whether or not Dr. William Hahn 2 met the acceptable standards of practice for a 3 practicing obstetrician? 4 A. Yes, I reviewed them. 5 Q. And do you have an opinion to a reasonable 6 degree of medical probability whether, in fact, he 7 did meet the acceptable standards of practice for a 8 practicing obstetrician? 9 A. Yes, he did. 10 Q. Doctor, you have talked about 11 pregnancy-induced hypertension, and what I want to do 12 now is just ask you a couple of questions about that, 13 okay? 14 A. Okay. 15 Q. For pregnancy-induced hypertension or the 16 preeclamptic/re-clamptic condition, do you give mag 17 sulfate? 18 A. Yes, you do. That's one treatment. 19 Q. Okay. In this particular case, you saw 20 that she had shaking and shivering at 3:50 in the 21 afternoon, correct? 22 A. Yes. 23 Q. Can you tell us whether or not the shaking 24 and the shivering could indeed be consistent with the 25 presence of pregnancy-induced hypertension or the 0037 1 delivery of even mag sulfate? 2 A. Well, people can react to mag sulfate like 3 that, although the -- when I approach patients, the 4 most -- as a clinician, again, the most ominous thing 5 would be if I had a lady with PIH, pregnancy-induced 6 hypertension, then I was called and she was shaking, 7 I'd be concerned she might be having a seizure which 8 can occur post-delivery also. 9 Q. Well, would a seizure be caused as a direct 10 result of an infection, like a Group A? 11 A. Only if you had a -- a brain abscess or 12 meningitis, but a uterine infection would not cause 13 the seizure. 14 Q. Later on, she had a temperature spike, 15 we've already talked about. Can you tell us whether 16 or not that is consistent with either the presence of 17 mag sulfate or is it consistent with PIH? 18 A. Patients do not usually have a fever after 19 mag sulfate, although they could have a reaction 20 which would cause a fever. On the other hand, the 21 more common scenario, if I had a patient with 22 pregnancy-induced hypertension and I was concerned 23 that that disease was progressing, you can get liver 24 necrosis, renal necrosis, and when tissue dies, fever 25 occurs, so if I had a patient having a seizure and a 0038 1 fever and had PIH, that would be a -- higher on my 2 list of concerns. 3 Q. Doctor, my last question for you is this: 4 After putting everything together, after reviewing 5 all of these records, reviewing the deposition, is it 6 your opinion, based upon reasonable medical 7 probability, that unfortunately the disease process 8 was going to progress and that even had antibiotics 9 been delivered, it would not have altered the 10 outcome? 11 A. That's my opinion. 12 MR. BONEZZI: Nothing further. Your 13 witness. 14 EXAMINATION 15 Q. (BY MR. PARIS) Doctor, my name is David 16 Paris, and I represent the Williams family. 17 You have experience in diagnosing and 18 treating postpartum infections; is that right? 19 A. Yes. 20 Q. And it's generally accepted that a fever in 21 a postpartum patient over 101 degrees Fahrenheit is 22 considered a fever; is that right? 23 A. Yes. 24 Q. In fact, it's generally accepted that a 25 single temperature of 101 Fahrenheit or greater 0039 1 within the first 24 hours of delivery constitutes a 2 fever? 3 A. Absolutely. 4 Q. And this has been generally accepted in 5 your professional circles for decades; is that right? 6 A. I would agree with that. 7 Q. Okay. And certainly a spiking fever within 8 the first 24 hours of delivery can be an important 9 sign and symptom of a serious postpartum infection, 10 can't it? 11 A. Yes. 12 Q. And, Doctor, do you believe that 13 antipyretics such as Tylenol, Motrin, ice packs can 14 artificially bring down the fever? 15 A. Over a short period of time, yes. 16 Q. And when a doctor is evaluating a patient 17 for a potential postpartum infection, he ought to 18 determine if the patient's fever is being 19 artificially held down by the use of antipyretics, 20 shouldn't he? 21 A. I would want to know that, yes. 22 Q. Now, whether you're talking about patients 23 who have a C-section or a vaginal delivery, there are 24 criteria for general -- for genital tract infections 25 which are common to both categories of patients, 0040 1 true? 2 A. Yes, there are some that are common. 3 Q. Fever is one common -- 4 A. Yes. 5 Q. -- criteria? 6 Lab values such as a white blood count 7 higher than 14,000 or greater than 15 percent bands, 8 that's another criteria? 9 A. Yes. 10 Q. And uterine or abdominal discomfort? 11 A. Yes. 12 Q. And these are criteria that you've been 13 using not only in your papers but in your own private 14 practice for 20 years? 15 A. Absolutely. 16 Q. Okay. Obviously an infection can become 17 more serious and develop into a condition known as 18 sepsis? 19 A. Yes. 20 Q. And you've helped us understand what sepsis 21 is; is that right? 22 A. Yes. 23 Q. And in your opinion, the criteria for 24 sepsis includes positive blood cultures? 25 A. Yes. 0041 1 Q. That is, with an organism growing? 2 A. (Nods head.) 3 Q. An elevated white blood count? 4 A. Well, yes, although the positive blood 5 cultures is the -- the most crucial one, but I would 6 agree with the elevated white count, yes. 7 Q. And bandemia? 8 A. Yes. 9 Q. Fever? 10 A. Yes. 11 Q. Chills? 12 A. Yes. 13 Q. Possibly hypotension? 14 A. Yes. 15 Q. Possibly tachypnea? 16 A. Yes. 17 Q. And tachypnea is what? 18 A. You breathe fast. 19 Q. And possibly tachycardia? 20 A. Your heart rate goes fast, yes. 21 Q. And the difference between sepsis and 22 septic shock is that sepsis progresses into septic 23 shock? 24 A. Shock would be when your body can't handle 25 it and the -- if you will, the engine stops working. 0042 1 Q. You've just told Mr. Bonezzi that -- that 2 your experience with Group A strep infections is very 3 limited; is that right? 4 A. My experience with Group A strep is 5 extensive, although I've only had one confirmed 6 case -- 7 Q. Okay. 8 A. -- because it's such a rare disease -- 9 Q. Right. 10 A. -- and that's -- the fact that I've seen a 11 case is extensive. 12 Q. It's your opinion that the mortality rate 13 or the death rate is 100 percent in -- in cases of 14 toxin-releasing Group A strep in a post-delivery 15 mother? 16 A. In this infection where it -- where it is 17 confirmed that that was the organism and a toxin was 18 released and the fact that the patient died 19 is -- is -- proves it. If the patient didn't die, 20 they didn't have this disease. 21 Q. So we're clear, it's your opinion that 22 mothers who have a toxin-releasing Group A strep 23 infection after the delivery will never survive? 24 A. That's right. 25 Q. Okay. And the professional literature that 0043 1 you are relying on to support that opinion is one 2 from the 1800s -- 3 A. No. 4 Q. -- written by Ignat Semilweiss, right? 5 A. No. Ignat Semilweiss, the father of this 6 discipline, even, that's -- you -- you asked me does 7 Ignat Semilweiss -- was that one of the largest 8 series, and this was pre-Pasteur where Group A strep 9 was felt to be the cause of death. Since that time, 10 there are no large series so -- 11 Q. I asked you that question in your 12 deposition -- 13 A. -- that's one of -- yes. That's not the 14 sole. 15 Q. The precise question that I asked you 16 was -- 17 MR. BONEZZI: Excuse me. What page is 18 that? 19 MR. PARIS: That's on Page 25 starting 20 at Line 12. 21 Q. (BY MR. PARIS) I asked you whether you had 22 any statistics that would support the proposition 23 that there's a 100 percent death rate and I asked you 24 if you could point us to any studies that support 25 that and you reported the classic study written by 0044 1 Ignat Semilweiss in the 1800s where they -- where 2 they had upwards of 20 percent maternal death rate -- 3 A. Right. 4 Q. -- in an organism they felt to be Group A 5 strep; is that right? 6 A. That's right. 7 Q. Is that what you told me? 8 A. That's right -- 9 Q. Okay. 10 A. -- and that's how this field in Group A 11 strep infections in pregnancy -- he is, if you will, 12 like Pasteur. That is the start of understanding 13 this disease. 14 Q. When in the 1800s was that paper written? 15 A. I'd have to check a reference to give you 16 the date, but it was in like -- between 1840 and 17 1870, as I recall. 18 Q. And that paper really concluded that 19 significantly less than 100 percent of those patients 20 with this infection go on to die, right? 21 A. No. The patients who died were felt to 22 have Group A strep. The patients who lived weren't 23 felt to have that. This is, again, pre-Pasteur. 24 This is when the disease entity like this woman had 25 was described, women who develop this and die. 0045 1 Q. And, of course, this is long before 2 the -- the antibiotic era? 3 A. Absolutely. 4 Q. Antibiotics weren't discovered and used 5 until when, after the 1940s? 6 A. After World War II. 7 Q. So any patients who survived this Group A 8 strep back in the 1800s survived it without 9 antibiotics? 10 A. Again, if they had toxin-producing Group A 11 strep, it's my opinion they didn't live. 12 Q. The fact is, Dr. Hammill, you can't point 13 us to one good study which supports the statement 14 that 100 percent of the post-delivery mothers who 15 have Group A strep toxins released will die. There's 16 no current study, similar study to that effect? 17 A. The -- again, to harken back to the 18 classics of medicine, in the old days, a good doctor 19 was someone who made the diagnosis and it was 20 confirmed at autopsy. This is similar to other 21 life-threatening conditions. When it is verified at 22 autopsy, the fact that this patient died, she falls 23 into that group of lethal toxin-producing Group A 24 strep. 25 Q. Is there a seminole study, Doctor, that 0046 1 will tell us -- 2 A. There is no seminole study because this is 3 such a rare disease and no one can -- as I said, my 4 experience, one delivery out of 36,000 so the 5 fact -- there is -- there is one variable. It's sort 6 of the denominator/enumerator question. You could 7 say -- like you could say how do you define this. In 8 my experience, understanding the disease from 9 Dr. Semilweiss on, is patients who develop this 10 condition are dead. 11 Q. Thank you. 12 The last time you authored anything 13 related to postpartum endometritis or postpartum 14 infections was in the early 1990s? 15 A. It may have been, yes. 16 Q. All right. Did you know that you're not 17 the only expert that Dr. Hahn hired in this case? Is 18 that right? 19 A. I don't know how many experts he hired. 20 Q. Well, have you been told that Dr. Hahn also 21 hired a board certified infectious disease expert by 22 the name of Dr. Martin Raff? 23 A. I believe that name was mentioned. 24 Q. You told me that you read his deposition? 25 A. I don't know if I saw -- I read lots of 0047 1 depositions. I believe I read that one. 2 Q. Did you ever speak with Dr. Raff about this 3 case? 4 A. No. 5 Q. You think you read his deposition -- 6 A. I'd have to see if it's in my pile there. 7 Q. Your pile is, I think, downstairs in your 8 office. 9 A. Or if you have it with you. 10 Q. It was -- it was taken on June 5th. Did 11 Mr. Bonezzi ever tell you or did you learn from his 12 deposition what Dr. Raff's opinions were about this 13 so-called 100 percent death rate you claim exists in 14 this disease process? 15 A. I'd have to look at the record to 16 specifically -- 17 Q. Did you learn that in Dr. Raff's opinion, 18 patients with this organism do not die 100 percent of 19 the time? 20 A. His experience may be different. 21 Q. Did you learn that in Dr. Raff's opinion, 22 the survivability of patients like Beth Williams 23 depend on various factors and those positive factors 24 include a patient who's young has a better chance of 25 surviving this organism, a patient who is healthy, a 0048 1 patient who is in the hospital at the onset of her 2 symptoms, a patient who is in an urban hospital 3 setting with ready access to infectious disease 4 specialists or who's 20 minutes from a high level 5 treatment center like University Hospitals? Did you 6 learn that from Dr. Raff's deposition? 7 A. I don't know if I -- 8 MR. BONEZZI: Objection. 9 A. -- I learned that from his, but I 10 will -- you want me to respond to that? 11 Q. (BY MR. PARIS) I just want to know if you 12 learned that from reading his deposition. 13 MR. BONEZZI: I'm not sure that he 14 even got it. 15 Q. (BY MR. PARIS) Okay. I'm just basing my 16 questions on what I thought I heard you say in your 17 direct examination, sir. 18 MR. BONEZZI: But I'm not sure that I 19 sent it to him. 20 Q. (BY MR. PARIS) Well, then, did Mr. Bonezzi 21 tell you that Dr. Raff testified that the delivery of 22 antibiotics to Beth before 11:30 p.m. on Friday night 23 may have altered the outcome in this case such that 24 the toxins may not have overcome her? 25 A. He may have said that. I don't agree with 0049 1 it. 2 MR. BONEZZI: For the record, I 3 haven't provided him any testimony as it relates to 4 Dr. Raff. 5 MR. PARIS: I can only go on what I 6 heard him say in his direct examination. 7 MR. BONEZZI: But he didn't say 8 anything about me providing him testimony. 9 Q. (BY MR. PARIS) Do you know that in 10 Dr. Raff's opinion, that some point during her stay 11 at Parma Hospital, if appropriate treatment had 12 begun, she was going to survive and the point where 13 she crossed over to where she was unlikely to survive 14 was 11:30 p.m. Friday night? Did you know he said 15 that? 16 MR. BONEZZI: Objection. 17 A. The -- if you're telling me he said that, I 18 have no reason to dispute it. 19 Q. (BY MR. PARIS) Okay. And so if Dr. Hahn's 20 other expert has expressed these opinions, you would 21 respectfully disagree with them? 22 A. I would say I have much different 23 experience being a specialist in this area. I don't 24 know if he's an internal medicine doctor that doesn't 25 deal with these patients too often. 0050 1 Q. But you disagree with him? 2 A. I would disagree with him, yes. 3 Q. And if plaintiffs' experts Dr. Jamofsky, 4 Dr. Crane, Dr. Mark Martins -- and there's no 5 question you read their testimony, right? 6 A. Yes. 7 Q. If they have opinions that Beth would have 8 survived even though she had Group A strep toxins 9 released in her system, you would disagree with them, 10 too? 11 A. I and God would disagree with them. 12 Q. Oh, you're on God's side in -- 13 A. Because she died. She died. 14 MR. BONEZZI: Objection. Move to 15 strike. 16 Q. (BY MR. PARIS) I'm sorry. Did you say you 17 were on God's side in -- 18 A. No. I said she died. 19 MR. BONEZZI: Objection. Move to 20 strike. 21 Q. (BY MR. PARIS) All the experts in this case 22 are wrong except you. Is that -- is that it? 23 A. No. I would say that their interpretation 24 and understanding of this disease entity may 25 be -- they may have less experience and they may see 0051 1 less -- one of the points in this case isn't just 2 that she had Group A strep. The other issue and the 3 point that may be missed through all of this is that 4 this woman presented with a life-threatening 5 condition of pregnancy-induced hypertension. 6 Q. Doctor, my question was are the other 7 experts in this case wrong except for you? And it's 8 a simple yes or no answer. 9 A. Yes. 10 Q. Okay. They're wrong and you're not, 11 correct? 12 A. That's my opinion. 13 Q. Okay. And as it relates to your time as an 14 expert witness, in the vast majority of medical 15 negligence cases, 70 percent -- 75 percent of the 16 time, you go to court with the doctors; is that 17 right? 18 A. I wouldn't say I go to court with the 19 doctors. It's uncommon that I have to go to trial. 20 Q. Well, 75 percent of the time, you work for 21 the doctors? 22 MR. BONEZZI: Objection. He doesn't 23 work for anybody. He provides opinions. 24 A. I would say that whether it's a 75 or 25 70/30, I review both cases, plaintiffs and 0052 1 defendants. There appear to be more cases, in my 2 experience, that are referred to me and I will agree 3 with that number that it is the defendants who are 4 physicians. 5 Q. (BY MR. PARIS) So if you testified in your 6 deposition that it was 75 percent of the time, you're 7 not going to go back on that? 8 A. I'm not going back on that. 9 Q. Doctor, you authored a report in this case 10 which is five lines long; is that right? 11 A. Yes. 12 Q. You read Beth's prenatal records, the whole 13 Parma Hospital chart? 14 A. Yes. 15 Q. The University Hospital chart? 16 A. Yes. 17 Q. The autopsy report -- 18 A. Yes. 19 Q. -- before you authored that and -- 20 A. Yes. 21 Q. -- having read those couple of hundred 22 pages, the five lines that you wrote basically 23 expressed two opinions; is that right? 24 A. I'd have to look at it to see if we put in 25 two -- 0053 1 Q. Well, the one opinion was the accepted 2 standard of medical care was met -- 3 A. Yes. 4 Q. -- with regard to Beth and, two, her death 5 was unpreventable? 6 A. Yes. 7 Q. And when you and I met the first time on 8 June 7th, you hadn't read any of the depositions of 9 the Parma Hospital nurses; is that right? 10 A. Correct. 11 Q. And you hadn't read the deposition of the 12 house officer, Dr. Shea? 13 A. Correct. 14 Q. And you hadn't even read the deposition of 15 Dr. Hahn, the man that hired you in this case; is 16 that right? 17 MR. BONEZZI: Dr. Hahn -- objection. 18 He did not hire him. 19 Q. (BY MR. PARIS) You're an expert for 20 Dr. Hahn in this case, aren't you? 21 MR. BONEZZI: Dr. Hahn didn't hire 22 him, and you know better than that. 23 Q. (BY MR. PARIS) I'm sorry. Dr. Hahn is the 24 doctor that you are performing these services for; is 25 that correct? 0054 1 A. I -- 2 MR. BONEZZI: Objection. Move to 3 strike. 4 A. -- am hired, I guess, by the law firm that 5 contacted me. 6 Q. (BY MR. PARIS) To render opinions on behalf 7 of Dr. Hahn? 8 A. Yes. 9 Q. And you had not even reviewed Dr. Hahn's 10 testimony before you authored that opinion, right? 11 A. That's true. 12 Q. When did -- when did you read these 13 depositions? 14 A. It was -- I'd have to look at the exact 15 date. It was months ago or a long time ago. 16 Q. No, no. As of June 7th, you hadn't read 17 Dr. Hahn's deposition? 18 A. Since then. Oh, I thought you meant when 19 did I read -- 20 Q. No. When did you read all this material? 21 A. Between now and since then. I had received 22 copies from the attorneys. 23 Q. So sometime in the past two weeks? 24 A. Yes, since I received them. It's been 25 within the past two weeks. 0055 1 Q. Even though in your entire career you've 2 only seen one patient with this toxin-releasing 3 Group A strep infection, do you believe that you're a 4 reliable authority on this subject? 5 A. Absolutely. 6 Q. And even though you haven't written 7 anything on the subject of postpartum infections of 8 the genital tract in seven or eight, nine years, you 9 believe that you're still a reliable authority on 10 this subject? 11 A. I've written a lot of books. Currently I'm 12 fighting the largest infectious disease endemic in 13 the world. That's why. I'm treating AIDS patients. 14 Q. That's HIV. 15 A. Every day, every day I deliver patients. 16 I'm still practicing clinical medicine, and I will 17 deliver almost 200 patients a year. I work at the 18 largest medical center in the world and in addition 19 to my academic training, I have the advantage of 20 being one of the busiest clinicians in infectious 21 diseases, so I would say not only am I qualified, I 22 may be more qualified because I actually see these 23 infections with the growing changes that occur with 24 organisms -- 25 Q. In this case -- 0056 1 A. -- so I'm not just in a classroom or an 2 office isolated. 3 Q. In this case, it's your opinion that Beth's 4 infection definitely first manifested itself when her 5 vital signs were erratically changing and they 6 started the antibiotics. Clearly, at that point, the 7 Group A strep toxins were released, right? 8 A. I would say that toxins -- in retrospect, 9 I'd have that opinion, yes. 10 Q. And, of course, they started the 11 antibiotics at 11:30 a.m. on Saturday morning? 12 A. I believe that's the time, yes. 13 Q. And Group A strep, that organism is very 14 sensitive to penicillin or Unasyn which kills the 15 bacteria almost immediately? 16 A. Absolutely, if it reaches the bacteria. 17 Q. And if the bacteria is killed before it 18 releases the toxins and if the antibiotic gets to the 19 site of the infection, it stops the release of 20 toxins, right? 21 A. We don't know what releases toxins. 22 Q. No, no. If the bacteria is killed before 23 it releases the toxins and if the antibiotics get to 24 the site of the infection before the release of 25 toxins, the toxins -- 0057 1 A. The exotoxin -- 2 Q. -- will not be released? 3 A. -- will not be released. The endotoxins 4 actually are released when the bacteria died. 5 Q. Exotoxins? 6 A. Exotoxins would be prevented. The 7 endotoxins are what are released when the bacteria 8 dies. 9 Q. And, of course, the effect of no penicillin 10 or no Unasyn, no antibiotics, is that the bacteria 11 keeps growing and releasing toxins, correct? 12 A. If the -- if the antibiotics get to the 13 bacteria and kill it, they don't produce exotoxins. 14 Q. And the fact is that you believe that 15 before the toxin was released, Beth could have 16 survived this? 17 A. If the toxin was never released, she'd be 18 alive today. 19 Q. And you just don't know when the toxins 20 were released. That's what you testified to in your 21 deposition, correct? 22 A. Sometime during her course. 23 Q. And the first toxins could have been 24 released after 7:30 p.m. Friday night, correct? 25 A. I don't know when the toxins were released. 0058 1 Q. I asked you that exact same question in 2 your deposition and you said they could have been 3 released after 7:30. 4 A. I would agree with that. 5 Q. And the first toxins could have been 6 released after 8:30 p.m. Friday night, correct? 7 A. Could have been. 8 Q. And you have no way of knowing one way or 9 the other whether there's a probability that the 10 toxins were released prior to 8:30, right? 11 A. Not necessarily because the pathology 12 report, with that degree of necrosis, would suggest 13 that with that extensive necrosis, that toxin release 14 in the nidus of infection, which was the uterus, were 15 being released even before any clinical symptoms 16 occurred because there was dead tissue there. 17 Q. We're going to talk about the -- this 18 extensive necrosis that you claim exists in the 19 autopsy in a little while. 20 Once a Group A strep toxin is released 21 into a person's bloodstream, you don't know how long 22 those toxins continue to produce harmful effects on 23 the body, do you? 24 A. It's a cascade effect. Once they're 25 released, they keep -- it triggers a response in the 0059 1 human. Yeah, I don't know exactly. I don't think 2 anyone knows. 3 Q. And you don't know if it's one toxin that 4 causes all these problems or if it's the effect of a 5 large amount of toxins that produces the septic shock 6 and death, right? 7 A. That's true. 8 Q. And when I first took your deposition under 9 oath a couple of weeks ago, you told me that the 10 Group A strep was found in Beth not through her blood 11 cultures but through testing of her uterus at 12 autopsy. Do you remember telling me that? 13 A. The autopsy report states Group A strep 14 pyogens as their diagnosis. That's what I was 15 referring to at that time. 16 Q. The fact of the matter is, is that the 17 bacteria, the Group A strep, was isolated in a blood 18 culture? 19 A. Yes, I'm aware of that. 20 Q. Okay. So if you said otherwise in your 21 deposition, you were wrong? 22 A. No. I was referring to the autopsy report 23 where they -- where they state Group A strep 24 pyogenese was present. That's what I was referring 25 to. 0060 1 Q. You agree with everyone in this case that 2 Dr. Hahn did suspect Beth had an infection as early 3 as 8:20 p.m. Friday night, right? 4 A. I agree he was -- that was in his 5 differential. 6 Q. And that's why he ordered at least a urine 7 culture and sensitivity and possibly a urinalysis; is 8 that right? 9 A. Yes. 10 Q. And even though Dr. Hahn was suspecting 11 Beth had an infection, it's your opinion that having 12 ordered tests like a urinalysis, a white blood count 13 with differentials -- "differentials" referring to 14 what, bands, neutrophils and metamyelocytes? 15 A. Correct. 16 Q. -- he was under no obligation to find out 17 what the results of those tests were? 18 A. I wouldn't say he's under no obligation to 19 find the results of the tests. 20 Q. He was under an obligation, then, to find 21 out the results of those tests, right? 22 A. We follow up on our test results, yes. 23 Q. If you order a test, you have to follow up 24 and find out what the results are? 25 A. Yes. 0061 1 Q. Is that the obligation of a physician? 2 A. That's why we order the test, so we get the 3 results. Absolutely. 4 Q. That's the accepted standard of care; is 5 that correct? 6 A. Yes. 7 Q. And is it your belief that a nurse who 8 looks at these tests like a white blood count with 9 differential has no obligation to tell the doctor who 10 ordered them that they are abnormal? 11 A. No, I wouldn't say she has no obligation to 12 tell him that. 13 Q. Well, if a nurse doesn't offer the 14 information, is the obligation of the doctor -- is it 15 the obligation of the doctor to ask? 16 A. We ask. The nurses aren't always 17 sophisticated enough to know -- to interpret all the 18 laboratory tests. 19 Q. Okay. So then the obligation really falls 20 squarely on the shoulders of the doctor? 21 A. Yes. 22 Q. Okay. If Dr. Hahn felt strongly that 23 nursing negligence led to a nine-hour delay in the 24 treatment and diagnosis of Beth's infection, didn't 25 he have the obligation to point that out in the 0062 1 hospital discharge summary that he dictated July 1st, 2 1999? 3 A. When I dictate my discharge summaries, I 4 dictate the facts of the case related to 5 metabolically what occurred with the patient, and I 6 would just state the facts of the record. I would 7 not give an opinion nor have I ever given an opinion 8 when I dictated a discharge summary if negligence 9 occurred or not. I dictate the facts and then 10 whether it's negligent or not is -- is sorted out. 11 Q. Well, how about just dictating in the 12 discharge summary the fact of a delay without 13 attributing it to negligence? Did he have an 14 obligation to do that? 15 A. I'm -- I would say that I'm not sure when 16 he was -- what was in his mind when he was dictating 17 the case. If you dictate a case, you dictate their 18 hospital course. Usually dictating a delay in 19 getting lab results -- if I dictated in every chart 20 there was a delay in getting lab results -- there's 21 always a delay and how you define "delay," is it an 22 hour, two hours? Computers break down. All the 23 computers in Houston are down. There's a delay in 24 getting everything. 25 Q. Well, Dr. Hahn -- 0063 1 MR. BONEZZI: Objection. 2 Q. (BY MR. PARIS) -- testified that there was 3 a nine-hour delay, and I want to know from you 4 whether -- if he didn't have that obligation to point 5 that out in the discharge summary, did he owe that 6 obligation of truthfulness to Beth's family? 7 MR. BONEZZI: Objection. Move to 8 strike. 9 A. I can't comment on that, whether he owed an 10 obligation to her in that regard or not. 11 Q. (BY MR. PARIS) Why not? 12 A. Because I'm not sure if that's relevant to 13 what actually transpired. 14 Q. Do you feel that it's acceptable for 15 Dr. Hahn to sweep that kind of alleged misconduct 16 under the carpet? 17 MR. BONEZZI: Objection. Move to 18 strike. 19 A. I'm not calling that misconduct in a delay 20 in that period or lack of delay in getting a lab 21 result. 22 Q. (BY MR. PARIS) He's calling it misconduct. 23 A. That's his opinion, not mine. 24 MR. BONEZZI: Objection. Move to 25 strike. 0064 1 Q. (BY MR. PARIS) The fact that this 2 condition, this Group A strep infection in a 3 postpartum vaginal delivery is rare doesn't mean that 4 you don't look for and try to diagnose and treat a 5 postpartum infection, the symptoms of this condition, 6 early on? 7 A. So I understand your question, if a patient 8 prevents -- presents with an infection, would you 9 treat it? Yes. 10 Q. Okay. And the fact that it turns out to be 11 a rare infection, a rare organism, doesn't mean that 12 you're not going to treat the symptoms? 13 A. No. 14 Q. Okay. You still have to treat the symptoms 15 when they present, right? 16 A. Yes. 17 Q. You spent some time talking to Mr. Bonezzi 18 about the necrosis that you saw in the autopsy in the 19 uterus. There was necrotic tissue in the uterus. 20 How large an area of necrosis did you see? 21 A. Well, they said it went to the perimetrium, 22 so that would be -- and it's not proportioned to the 23 size of my body, but if the uterus postpartum is 24 about the -- not quite as big as a football and it 25 spread all the way out to the blood vessels on the 0065 1 side so -- "big" is a relative term. 2 Q. Well, let me ask you this: Did it engulf 3 the entire perimetrial tissues on both sides of the 4 uterus? 5 A. It just says perimetrial tissues, but that 6 means it spread all the way through the thickness of 7 the lining of the uterus out to the blood supply. 8 Q. That's depth, but how about the length and 9 width? 10 A. Well, the anatomy, it's only a few 11 centimeters, sort of like the spinal column is very 12 narrow. It's less than a millimeter, yet if the 13 bacteria cross that, you're dead, so the dimensions 14 aren't so important as the idea that it spread from 15 the lining of the uterus all the way into the area of 16 the perimetrium where the vessels are suggesting that 17 the uterus was being devascularized as the infection 18 progressed. 19 Q. And the fact -- 20 A. The highways are being cut off. 21 Q. Understood, and you made that analogy very 22 clear. If the highways are cut off, that means the 23 antibiotics cannot come in -- 24 A. Absolutely. 25 Q. -- to treat that localized area of 0066 1 infection? 2 A. Correct. 3 Q. And if the highways are cut off, doesn't 4 that also mean that the toxins don't have a way of 5 getting out into the bloodstream? 6 A. Unfortunately, the toxins are smaller and 7 seep out, and it's sort of like when you have a blood 8 pressure cuff on. The veins will -- will not cause 9 blood return but the arteries are cut off, so the 10 toxins can seep and sort of eat through tissue and 11 then get to vessels and then spread, so I wish it 12 worked that way, but it doesn't. 13 Q. And the fact that you claim that there is a 14 devascularization of the uterus after the placenta is 15 delivered which also impairs the ability of 16 antibiotics to get to the uterus; is that right? 17 A. There's a devascularization to that bed, 18 that site where the placenta bed is raw. That's why 19 women don't bleed after deliveries. 20 Q. Well, but there is some bleeding after 21 delivery? 22 A. Absolutely. 23 Q. In this case, Beth had a moderate amount of 24 bleeding -- 25 A. And if the uterus -- 0067 1 Q. -- didn't she? 2 A. Yes, and if the uterus didn't contract 3 down, women would bleed to death -- 4 Q. That's right -- 5 A. -- after birth. 6 Q. -- but the fact that there is some moderate 7 amount of bleeding which was noted in Beth is also 8 evidence of the fact that there was some 9 vascularization to the uterus? 10 A. Absolutely, what's described as a normal 11 delivery bleeding. 12 Q. Okay. And to the extent that there was 13 some vascularization, there were some pathways, 14 roadways, highways, if you will, for antibiotics to 15 make their way to that site, correct? 16 A. At that moment immediately after birth, 17 yes. 18 Q. Bed was admitted to the hospital with 19 preeclampsia that was characterized as mild. Is that 20 true? 21 A. Yes, I believe that's true. 22 Q. Was that a severe form of preeclampsia? 23 A. I don't use the gradations mild, moderate, 24 severe because this is a disease that can progress 25 rapidly and once you've reached severe, you're in 0068 1 trouble, so you either have PIH or not. It's like 2 being -- 3 Q. Mr. Bonezzi asked you to characterize the 4 virulence of this by extrapolating her different lab 5 values between 5:00 p.m. and 11:30 p.m. Do you 6 recall that? 7 A. Yes. 8 Q. And you -- it was your opinion, based upon 9 those lab values, that there were definite signs of 10 infection based upon those lab values that would 11 concern you; is that right? 12 A. Yes. 13 Q. I mean, you would be concerned with lab 14 values like that? 15 A. Absolutely. 16 Q. Yet, when I asked you that question on 17 Page 53 of your deposition and continuing into 18 Page 54, I asked you retrospectively to characterize 19 the severity of her infection at 11:30 and I asked 20 you to take into consideration those labs and -- and 21 anything else you wanted to take into consideration, 22 you ended the answer of that question by saying, "At 23 that point, based on what I read, I would not suspect 24 that this patient had a life-threatening infection"? 25 A. Absolutely. 0069 1 Q. Okay. 2 A. Especially -- 3 Q. Retrospectively? 4 A. -- light-threatening, you know. 5 Q. Thank you very much, Doctor. I don't have 6 anything further. 7 MR. BONEZZI: No further questions, 8 Doctor. I thank you very much, sir. 9 THE VIDEOGRAPHER: It's June 22nd, 10 10:47 a.m. We are now off the record. 11 (Proceedings concluded at 10:47 a.m.) 12 13 14 15 16 17 18 19 20 21 22 23 24 25 0070 1 I declare under penalty of perjury that the 2 foregoing is true and correct. 3 4 5 HUNTER HAMMILL, M.D. 6 7 8 SUBSCRIBED AND SWORN TO BEFORE ME, the 9 undersigned authority, by the witness, HUNTER 10 HAMMILL, M.D., on this the day of , 11 . 12 13 14 NOTARY PUBLIC IN AND FOR 15 THE STATE OF 16 17 My Commission Expires: 18 19 20 21 22 23 24 25 0071 1 STATE OF TEXAS 2 COUNTY OF HARRIS 3 4 REPORTER'S CERTIFICATE 5 ORAL VIDEOTAPED DEPOSITION OF HUNTER HAMMILL, M.D. 6 June 23, 2001 7 8 I, the undersigned Certified Shorthand Reporter 9 in and for the State of Texas, certify that the facts 10 stated in the foregoing pages are true and correct. 11 I further certify that I am neither attorney or 12 counsel for, related to, nor employed by any parties 13 to the action in which this testimony is taken and, 14 further, that I am not a relative or employee of any 15 counsel employed by the parties hereto or financially 16 interested in the action. 17 SUBSCRIBED AND SWORN TO under my hand and seal 18 of office on this the day of , 19 . 20 21 22 Vickie G. Hildebrandt, CSR Texas CSR 1363 23 Expiration: 12/31/01 UNITED-WOMACK REPORTING 24 (713)426-0400 25